[Venous thromboembolism in patients with acute tuberculosis]

Rev Pneumol Clin. 2015 Dec;71(6):327-34. doi: 10.1016/j.pneumo.2015.04.004. Epub 2015 Jul 17.
[Article in French]

Abstract

Background: Studies have demonstrated a link between tuberculosis and hypercoagulable state, with reported rates of 0,6%-10% venous thromboembolism (VTE) in all adults with tuberculosis. The present study aimed to evaluate the current incidence and characteristics of VTE in a large sample of patients with acute tuberculosis.

Methods: We report a retrospective study about 26 patients who have confirmed tuberculosis complicated with VTE disease.

Results: Sixteen men and ten women were brought together. The mean age was 42.58 years. The thromboembolic complication revealed tuberculosis among 5 patients, appearing during hospitalization of 21 patients among which 16 of them receiving antituberculosis drug. We have listed 10 cases of immediate pulmonary thromboembolism and 16 cases of deep vein thrombosis complicated with pulmonary embolism in 6 cases. Oral anticoagulation drug were associated with heparin after a mean of 4.57 days. Duration average of achievement of an effective dose was of 21.05 days and we prescribe low molecular weight heparin for 6 months on 2 cases. There was favorable evolution among 14 patients, 4 of them have lost sight and the evolution was fatal by cataclysmic haemoptysis in one case, a patient died hepatocellular insufficiency and 6 died by pulmonary embolism.

Conclusion: Immunological and hematological abnormalities are incriminated in the genesis of VTE disease during tuberculosis by creating hypercoagulate state. The accumulation of morbidity of these two affections as well as the difficulty of therapeutic care made by medical interaction ifampicin-anticoagulants aggravate the prognostic.

Keywords: Embolie pulmonaire; Facteurs de risque; Pulmonary embolism; Risk factors; Thrombose veineuse; Tuberculose; Tuberculosis; Venous thrombosis.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use
  • Female
  • Heparin / therapeutic use
  • Humans
  • Male
  • Pulmonary Embolism / complications
  • Pulmonary Embolism / diagnosis
  • Pulmonary Embolism / drug therapy
  • Retrospective Studies
  • Tuberculosis, Pulmonary / complications*
  • Tunisia
  • Venous Thromboembolism / complications*
  • Venous Thromboembolism / diagnosis
  • Venous Thromboembolism / drug therapy
  • Young Adult

Substances

  • Anticoagulants
  • Heparin